245 related articles for article (PubMed ID: 32881478)
21. Comparative Genomic and Transcriptomic Analysis of Naegleria fowleri Clinical and Environmental Isolates.
Joseph SJ; Park S; Kelley A; Roy S; Cope JR; Ali IKM
mSphere; 2021 Aug; 6(4):e0063721. PubMed ID: 34378985
[TBL] [Abstract][Full Text] [Related]
22. Oleic Acid Coated Silver Nanoparticles Showed Better
Rajendran K; Anwar A; Khan NA; Aslam Z; Raza Shah M; Siddiqui R
ACS Chem Neurosci; 2020 Aug; 11(16):2431-2437. PubMed ID: 31347828
[No Abstract] [Full Text] [Related]
23. The first association of a primary amebic meningoencephalitis death with culturable Naegleria fowleri in tap water from a US treated public drinking water system.
Cope JR; Ratard RC; Hill VR; Sokol T; Causey JJ; Yoder JS; Mirani G; Mull B; Mukerjee KA; Narayanan J; Doucet M; Qvarnstrom Y; Poole CN; Akingbola OA; Ritter JM; Xiong Z; da Silva AJ; Roellig D; Van Dyke RB; Stern H; Xiao L; Beach MJ
Clin Infect Dis; 2015 Apr; 60(8):e36-42. PubMed ID: 25595746
[TBL] [Abstract][Full Text] [Related]
24. Activities of therapeutic agents against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.
Goswick SM; Brenner GM
J Parasitol; 2003 Aug; 89(4):837-42. PubMed ID: 14533700
[TBL] [Abstract][Full Text] [Related]
25. Use of the Novel Therapeutic Agent Miltefosine for the Treatment of Primary Amebic Meningoencephalitis: Report of 1 Fatal and 1 Surviving Case.
Cope JR; Conrad DA; Cohen N; Cotilla M; DaSilva A; Jackson J; Visvesvara GS
Clin Infect Dis; 2016 Mar; 62(6):774-6. PubMed ID: 26679626
[TBL] [Abstract][Full Text] [Related]
26. Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
Kim JH; Jung SY; Lee YJ; Song KJ; Kwon D; Kim K; Park S; Im KI; Shin HJ
Antimicrob Agents Chemother; 2008 Nov; 52(11):4010-6. PubMed ID: 18765686
[TBL] [Abstract][Full Text] [Related]
27. Risk for transmission of Naegleria fowleri from solid organ transplantation.
Roy SL; Metzger R; Chen JG; Laham FR; Martin M; Kipper SW; Smith LE; Lyon GM; Haffner J; Ross JE; Rye AK; Johnson W; Bodager D; Friedman M; Walsh DJ; Collins C; Inman B; Davis BJ; Robinson T; Paddock C; Zaki SR; Kuehnert M; DaSilva A; Qvarnstrom Y; Sriram R; Visvesvara GS
Am J Transplant; 2014 Jan; 14(1):163-71. PubMed ID: 24279908
[TBL] [Abstract][Full Text] [Related]
28. The anti-amoebic activity of Pinus densiflora leaf extract against the brain-eating amoeba Naegleria fowleri.
Lê HG; Kim W; Kang JM; Võ TC; Yoo WG; Cheong H; Na BK
Parasites Hosts Dis; 2024 May; 62(2):169-179. PubMed ID: 38835258
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of an adolescent with Naegleria fowleri primary amebic meningoencephalitis.
Linam WM; Ahmed M; Cope JR; Chu C; Visvesvara GS; da Silva AJ; Qvarnstrom Y; Green J
Pediatrics; 2015 Mar; 135(3):e744-8. PubMed ID: 25667249
[TBL] [Abstract][Full Text] [Related]
30. Fluvastatin and atorvastatin induce programmed cell death in the brain eating amoeba Naegleria fowleri.
Rizo-Liendo A; Sifaoui I; Arberas-Jiménez I; Reyes-Batlle M; Piñero JE; Lorenzo-Morales J
Biomed Pharmacother; 2020 Oct; 130():110583. PubMed ID: 32745907
[TBL] [Abstract][Full Text] [Related]
31. Drug discovery for primary amebic meningoencephalitis: from screen to identification of leads.
Debnath A
Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1099-1106. PubMed ID: 33496193
[No Abstract] [Full Text] [Related]
32. In Vitro Activity of Statins against
Rizo-Liendo A; Sifaoui I; Reyes-Batlle M; Chiboub O; Rodríguez-Expósito RL; Bethencourt-Estrella CJ; San Nicolás-Hernández D; Hendiger EB; López-Arencibia A; Rocha-Cabrera P; Piñero JE; Lorenzo-Morales J
Pathogens; 2019 Aug; 8(3):. PubMed ID: 31398829
[No Abstract] [Full Text] [Related]
33. Epidemiology and Clinical Characteristics of Primary Amebic Meningoencephalitis Caused by Naegleria fowleri: A Global Review.
Gharpure R; Bliton J; Goodman A; Ali IKM; Yoder J; Cope JR
Clin Infect Dis; 2021 Jul; 73(1):e19-e27. PubMed ID: 32369575
[TBL] [Abstract][Full Text] [Related]
34. Estimation of Undiagnosed Naegleria fowleri Primary Amebic Meningoencephalitis, United States
Matanock A; Mehal JM; Liu L; Blau DM; Cope JR
Emerg Infect Dis; 2018 Jan; 24(1):162-164. PubMed ID: 29260676
[TBL] [Abstract][Full Text] [Related]
35. Successful Treatment of Confirmed Naegleria fowleri Primary Amebic Meningoencephalitis.
Burqi AMK; Satti L; Mahboob S; Anwar SOZ; Bizanjo M; Rafique M; Ghanchi NK
Emerg Infect Dis; 2024 Apr; 30(4):803-805. PubMed ID: 38526236
[TBL] [Abstract][Full Text] [Related]
36. Role of cathepsin B of Naegleria fowleri during primary amebic meningoencephalitis.
Rodríguez-Mera IB; Carrasco-Yépez MM; Vásquez-Moctezuma I; Correa-Basurto J; Salinas GR; Castillo-Ramírez DA; Rosales-Cruz É; Rojas-Hernández S
Parasitol Res; 2022 Nov; 121(11):3287-3303. PubMed ID: 36125528
[TBL] [Abstract][Full Text] [Related]
37. Development of a high- versus low-pathogenicity model of the free-living amoeba Naegleria fowleri.
Burri DC; Gottstein B; Zumkehr B; Hemphill A; Schürch N; Wittwer M; Müller N
Microbiology (Reading); 2012 Oct; 158(Pt 10):2652-2660. PubMed ID: 22878396
[TBL] [Abstract][Full Text] [Related]
38. Natural Terpenes Inhibit the Cytopathogenicity of
Rajendran K; Ahmed U; Meunier AC; Shaikh MF; Siddiqui R; Anwar A
ACS Chem Neurosci; 2023 Dec; 14(23):4105-4114. PubMed ID: 37983556
[No Abstract] [Full Text] [Related]
39. Swimming with death: Naegleria fowleri infections in recreational waters.
Heggie TW
Travel Med Infect Dis; 2010 Jul; 8(4):201-6. PubMed ID: 20970721
[TBL] [Abstract][Full Text] [Related]
40. Identification and significance of Naegleria fowleri isolated from the hot spring which related to the first primary amebic meningoencephalitis (PAM) patient in Taiwan.
Tung MC; Hsu BM; Tao CW; Lin WC; Tsai HF; Ji DD; Shen SM; Chen JS; Shih FC; Huang YL
Int J Parasitol; 2013 Aug; 43(9):691-6. PubMed ID: 23665128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
